PHASE I DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND PHARMACOKINETICS OF ORAL ARTESUNATE IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (DESPARTH TRIAL)

被引：0
|
作者：
Vandewynckel, Y. -P. [1 ]
Rombauts, K. [2 ]
Verhelst, X. [1 ]
Van Bortel, L. [3 ]
De Spiegeleer, B. [4 ]
Geerts, A. [1 ]
Van Vlierberghe, H. [1 ]
机构：
[1] Univ Ghent, Dept Gastroenterol & Hepatol, B-9000 Ghent, Belgium
[2] Anticanc Fund, Strombeek Bever, Belgium
[3] Univ Ghent, Fac Pharmaceut Sci, Clin Pharmacol & Pharmacotherapy, B-9000 Ghent, Belgium
[4] Univ Ghent, Fac Pharmaceut Sci, Lab Drug Qual & Registrat, B-9000 Ghent, Belgium
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)31522-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1343
引用
收藏
页码：S860 / S860
页数：1
相关论文
共 50 条
  • [1] Phase I dose-escalation trial evaluating the safety and pharmacokinetics of sorafenib combined with capecitabine in patients with advanced solid tumors
    Awada, A.
    Gil, T.
    Whenham, N.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Loembe, B.
    Piccart, M.
    Hendlisz, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 39 - 39
  • [2] Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
    Sarantopoulos, John
    Mita, Alain C.
    He, Aiwu
    Wade, James L.
    Hsueh, Chung-Tsen
    Morris, John C.
    Lockhart, A. Craig
    Quinn, David I.
    Hwang, Jimmy
    Mier, James
    Zhang, Wenping
    Wack, Claudine
    Yin, Jian
    Clot, Pierre-Francois
    Rixe, Olivier
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (02) : 339 - 351
  • [3] Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study
    John Sarantopoulos
    Alain C. Mita
    Aiwu He
    James L. Wade
    Chung-Tsen Hsueh
    John C. Morris
    A. Craig Lockhart
    David I. Quinn
    Jimmy Hwang
    James Mier
    Wenping Zhang
    Claudine Wack
    Jian Yin
    Pierre-François Clot
    Olivier Rixe
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 339 - 351
  • [4] A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors
    Leong, Stephen
    Moss, Rebecca A.
    Bowles, Daniel W.
    Ware, Joseph A.
    Zhou, Jing
    Spoerke, Jill M.
    Lackner, Mark R.
    Shankar, Geetha
    Schutzman, Jennifer L.
    van der Noll, Ruud
    Voest, Emile E.
    Schellens, Jan H. M.
    ONCOLOGIST, 2017, 22 (12): : 1491 - 1499
  • [5] A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours
    Li, Xiaoyu
    Qiu, Meng
    Wang, ShengJun
    Zhu, Hong
    Feng, Bi
    Zheng, Li
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (03) : 593 - 604
  • [6] A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours
    Xiaoyu Li
    Meng Qiu
    ShengJun Wang
    Hong Zhu
    Bi Feng
    Li Zheng
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 593 - 604
  • [7] A phase I dose-escalation study to evaluate pharmacokinetics, safety and tolerability of ACT001 in patients with advanced glioma.
    Shi, Yehui
    Bai, Guiying
    Wang, Peng
    Cai, Dongpo
    Chen, Yue
    Wang, Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma
    Petrylak, Daniel P.
    Eigl, Bernhard J.
    George, Saby
    Heath, Elisabeth I.
    Hotte, Sebastien J.
    Chism, David D.
    Nabell, Lisle M.
    Picus, Joel
    Cheng, Susanna Y.
    Appleman, Leonard J.
    Sonpavde, Guru P.
    Morgans, Alicia K.
    Pourhosseini, Pourya
    Wu, Ruishan
    Standley, Laura
    Croitoru, Ruslan
    Yu, Evan Y.
    CLINICAL CANCER RESEARCH, 2024, 30 (01) : 63 - 73
  • [9] Phase I dose-escalation study of nintedanib in Japanese patients with advanced hepatocellular carcinoma (HCC) and mild or moderate liver impairment
    Ikeda, M.
    Otsuka, T.
    Ueno, H.
    Mitsunaga, S.
    Sugimoto, R.
    Muro, K.
    Saito, I.
    Sasaki, T.
    Inoue, K.
    Loembe, A. B.
    Okusaka, T.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S454 - S454
  • [10] Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma
    Kim, Tae Hyun
    Park, Joong-Won
    Kim, Yeon-Joo
    Kim, Bo Hyun
    Woo, Sang Myung
    Moon, Sung Ho
    Kim, Sang Soo
    Koh, Young-Hwan
    Lee, Woo Jin
    Park, Sang Jae
    Kim, Joo-Young
    Kim, Dae Yong
    Kim, Chang-Min
    CANCER RESEARCH AND TREATMENT, 2015, 47 (01): : 34 - 45
12345